# PREMIER BIOMEDICAL INC

PREMIER BIOMEDICAL INC is a company headquartered in Whitefish, MT, United States.

## Company overview

- **Legal name:** PREMIER BIOMEDICAL INC
- **Classification:** Company
- **Industry (SIC):** 2836 — Biological Products, (No Diagnostic Substances)
- **Headquarters:** Whitefish, MT, United States
- **Incorporated in:** NV
- **Fiscal year end:** December 31
- **SEC CIK:** 0001515740

## About

PREMIER BIOMEDICAL INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001515740, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2020-05-15, it reported annual revenue of USD 14,281; net income of USD -374,470; total assets of USD 100,943 for the fiscal period ended 2019-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2019 (period ended 2019-12-31)

- **Revenue:** $14,281 (USD 14,281)
- **Net income:** -$374,470 (USD -374,470)
- **Total assets:** $100,943 (USD 100,943)
- **Operating cash flow:** -$344,180 (USD -344,180)

### FY2018 (period ended 2018-12-31)

- **Revenue:** $39,795 (USD 39,795)
- **Net income:** -$398,886 (USD -398,886)
- **Total assets:** $164,990 (USD 164,990)
- **Operating cash flow:** -$444,878 (USD -444,878)

### FY2017 (period ended 2017-12-31)

- **Revenue:** $39,761 (USD 39,761)
- **Net income:** -$3.8M (USD -3,763,558)
- **Total assets:** $209,081 (USD 209,081)
- **Operating cash flow:** -$509,432 (USD -509,432)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2016 (period ended 2016-12-31)

- **Net income:** -$1.8M (USD -1,768,221)
- **Total assets:** $38,967 (USD 38,967)
- **Operating cash flow:** -$483,622 (USD -483,622)

## Recent SEC filings

- Form 10-K/A — filed 2020-06-01 — period 2019-12-31 — AMENDMENT NO 1
- Form 8-K — filed 2020-06-01 — period 2020-05-26 — CURRENT REPORT
- Form 8-K — filed 2020-06-01 — period 2020-05-22 — CURRENT REPORT
- Form 10-K — filed 2020-05-15 — period 2019-12-31 — ANNUAL REPORT
- Form 8-K — filed 2020-05-15 — period 2020-05-15 — CURRENT REPORT
- Form 8-K — filed 2020-05-14 — period 2020-05-11 — CURRENT REPORT
- Form 8-K — filed 2020-05-07 — period 2020-05-02 — CURRENT REPORT
- Form 8-K — filed 2020-03-30 — period 2020-03-30 — CURRENT REPORT
- Form S-1 — filed 2019-12-10 — REGISTRATION STATEMENT
- Form 10-Q — filed 2019-11-14 — period 2019-09-30 — QUARTERLY REPORT
- Form 8-K — filed 2019-10-09 — period 2019-10-04 — CURRENT REPORT
- Form 8-K — filed 2019-09-17 — period 2019-09-13 — CURRENT REPORT

---

Updated: 2026-10-23T20:09:28Z

Canonical page: https://altss.com/profile/premier-biomedical-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology